甲状腺癌术后残余癌放疗效果分析

Analyse Thyroid Carcinoma Postoperative Residual Carcinoma Radiotherapy's Effects

目的:探究甲状腺癌术后残余癌放疗的临床效果。方法:选取我院收治的甲状腺癌术后患者60例,将其作为临床研究对象,所有患者术后经病理诊断确诊为有残余癌,患者均进行残余癌放疗,观察放疗后患者的生存率情况。结果:3年、5年、10年后患者的存活率分别为为90.0%、78.33%%、58.33%。治疗后3年、5年、10年髓样癌患者的生存率最低。放射剂量>50Gy的患者的生存率高。P<0.05,具有统计学意义。结论:甲状腺癌患者术后残余癌经放疗效果好,病理类型、放射剂量均与患者的生存率有关,放射剂量以50～75Gy为宜。

Objective： To discuss thyroid carcinoma postoperative residual carcinoma radiotherapy’s clinical effects.Methods：Chose 60 cases of those postoperative thyroid carcinoma patients who have been nadmitted at our hospital as clinical study objectives,and all of them have been diagnosed as residual carcinoma patients through pathology diagnosis,and proceeded residual carcinoma radiotherapy for all patients,observed patients’survival rate adter radiotherapy.Results：Patients’ survival rates were 93.3%,86.67%,78.33% after 3,5 and 10 years respectively,and medullary carcinoma patients’ survival rates after 3,5 and 10 years were the lowest.Patients’（whose radiological dose＆gt;50Gy） survival rate was obviously higher than those patients’（whose radiological dose＆lt;50Gyde）,P＆lt;0.05,and it has statistics meaning.Conclusions： Thyroid carcinoma postoperative residual carcinoma radiotherapy has good effects on thyroid patients,pathological type and radiation dose are related to patients’ survival rate,and it is appropriate to use radiological dose between 50Gy and 75Gy.